NCT01246921: Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo |
|
|
| Unknown status | 4 | 50 | Europe | Fluticasone proprionate 0.05% cream, Cutivate cream | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Patients With Active Non-segmental Vitiligo., Evaluation of the Efficacy of UVB and Fluticason Proprionate 0.05%, Cream Compared to NB-UVB Alone in Patients With Non-segmental Vitiligo | 08/11 | | | |
2008-006903-22: Narrow band UV-B phototherapy and fluticasone proprionate versus narrow band UV-B phototherapy and placebo for the treatment of active vitiligo: a randomized double blind controlled trial |
|
|
| Ongoing | 4 | 64 | Europe | Cutivate, RVG06933, Cutivate, Cutivate | Academic Medical Center | Narrow band ultra violet B phototherapy is the gold standard for the treatment of vitiligo vulgaris. Ultra violet A and fluticasone proprionate (cutivate) together have shown significant better repigmentation than both treatments alone in a study by Westerhof et al in 1999. We expect that the combination of narrow band ultra violet B and fluticasone proprionate will have a significantly better result in terms of repigmentation for the treatment of vitiligo. | | | | |
